US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Russell Investments Core Plus Bond ETF

24.74

-0.0256-0.10%

Post-market: 24.760.0256+0.10%16:04 EDT

Volume:39

Turnover:965

Market Cap:59.86M

PE:- -

High:24.74

Open:24.76

Low:24.74

Close:24.76

52wk High:25.19

52wk Low:24.72

Shares:2.42M

Float Shares:2.42M

Volume Ratio:0.80

T/O Rate:0.00%

Dividend:0.12

Dividend Rate:0.49%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Keymed Biosciences Announces 2026 H1 Results and Business Updates

Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release

Keymed Biosciences Turns Profitable on Surging Drug Sales and BD Windfall

Domestic Insulin Giant Secures Major Overseas Licensing Deal, Can Weight-Loss Drug Unlock a New Growth Trajectory?

Three Major Cross-Border Deals Land on Same Day, Boosting Sentiment for Chinese Innovative Drug Outbound Licensing; T+0 Huatai Baorui Hang Seng Innovative Drug ETF (520500) Attracts Over 2.5 Billion Yuan in Net Inflows Over the Past Year

Press Release: Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results

BD Fiscal Q3 2026 Earnings: Revenue Grows as GAAP Operating Profit Falls

Innovative Drug BD Deals Surpass 100 Billion in First Half, Signaling a Positive Long-Term Trend?

Insights from Biocytogen's CEO: The Fast-Track Four-Month BD Deal

Dalian's Dual Approach to Taxi Regulation: Strict Enforcement Meets Cultural Ambassadorship

AeroVironment in contract talks with U.S. Army over E-HEL program, BD says

Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says

MT Newswires Live

Domestic Innovative Drug Secures Another Major $1.9 Billion Out-Licensing Deal, Sparking Rebound in Hong Kong Connect Pharma Sector

Hong Kong Stock Connect Biotech Stocks Surge, Leading ETF Jumps Over 3% as Record-High Licensing Deals Signal a Paradigm Shift

Advent Hotels consolidates BD and P Hotels preference shares to back new debenture funding

Is Vizient’s Nod to BD CentroVena One Quietly Reframing Becton Dickinson’s (BDX) Competitive Moat?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BD\",,,,,undefined,":{"symbol":"BD","market":"US","secType":"STK","nameCN":"Russell Investments Core Plus Bond ETF","latestPrice":24.735,"timestamp":1787342400000,"preClose":24.7606,"halted":0,"volume":39,"hourTrading":{"tag":"盘后","latestPrice":24.7606,"preClose":24.735,"latestTime":"16:04 EDT","volume":2,"amount":49.47,"timestamp":1787342650304,"change":0.0256,"changeRate":0.001035,"amplitude":0},"delay":0,"changeRate":-0.0010339006324564322,"floatShares":2420004,"shares":2420004,"eps":0,"marketStatus":"Market Closed","change":-0.0256,"latestTime":"08-21 16:00:00 EDT","open":24.7606,"high":24.735,"low":24.735,"amount":965,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":24.7606,"nav":24.69152,"aum":59753478.67,"dividendRate":0.004881,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.7606,"preClose":24.735,"latestTime":"16:04 EDT","volume":2,"amount":49.47,"timestamp":1787342650304,"change":0.0256,"changeRate":0.001035,"amplitude":0},"volumeRatio":0.7991816380026854},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BD\",,,,,undefined,":{"symbol":"BD","floatShares":2420004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7991816380026854,"shares":2420004,"dividePrice":0.120736,"high":24.735,"amplitude":0,"preClose":24.7606,"low":24.735,"week52Low":24.72,"pbRate":"--","week52High":25.19,"institutionHeld":0,"latestPrice":24.735,"eps":0,"divideRate":0.004881,"volume":39,"delay":0,"ttmEps":0,"open":24.7606,"prevYearClose":25.08,"prevWeekClose":24.775,"prevMonthClose":24.7678,"prevQuarterClose":25.19,"fiveDayClose":24.775,"twentyDayClose":24.795},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BD\",params:#limit:5,,,undefined,":[{"date":"2026-08-04","symbol":"BD","amount":0.120736,"announcedDate":"2026-08-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-04","defaultRemindTime":1785850200000,"name":"Russell Investments Core Plus Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-06","payableDate":"2026-08-04","currency":"USD","dateTimestamp":1785816000000,"payDate":"2026-08-06"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BD\",market:\"US\",,,undefined,":[{"executeDate":"2026-08-04","recordDate":"2026-08-04","paymentDate":"2026-08-06","value":0.120736,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660232280","title":"Press Release: Keymed Biosciences Announces 2026 H1 Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2660232280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660232280?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:10","pubTimestamp":1787235000,"startTime":"0","endTime":"0","summary":"CHENGDU, China, Aug. 20, 2026 /PRNewswire/ -- On August 19, 2026, Keymed Biosciences (HKEX: 02162) announced its interim results for the six months ended June 30, 2026. Guided by a clear dual-engine d","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BD","BK4096","PN","BK1587","BK1583","02162","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102229692","title":"Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1102229692","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102229692?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:36","pubTimestamp":1787193374,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) jumped more than 5% in early trading on Wednesday, with shares last up 4.27% at HK$12.69, recording a turnover of HK$40.17 million. The stock's upward momentum comes as...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BD","02096","BK4588","159992","IBBQ","BK1191","KCAI","BK1583","MEDX","LNGR","VXUS","BK1574","BK1161","BK4585","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660426686","title":"Keymed Biosciences Turns Profitable on Surging Drug Sales and BD Windfall","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426686","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660426686?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:39","pubTimestamp":1787146746,"startTime":"0","endTime":"0","summary":"An announcement from Keymed Biosciences, Inc. ( ($HK:2162) ) is now available. Keymed Biosciences reported strong interim results for the six month...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/keymed-biosciences-turns-profitable-on-surging-drug-sales-and-bd-windfall?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/keymed-biosciences-turns-profitable-on-surging-drug-sales-and-bd-windfall?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183720612","title":"Domestic Insulin Giant Secures Major Overseas Licensing Deal, Can Weight-Loss Drug Unlock a New Growth Trajectory?","url":"https://stock-news.laohu8.com/highlight/detail?id=1183720612","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183720612?lang=en_us&edition=fundamental","pubTime":"2026-08-16 17:10","pubTimestamp":1786871446,"startTime":"0","endTime":"0","summary":"In recent years, China's biomedical industry has been accelerating its development, with pharmaceutical companies signing major overseas Business Development (BD) deals. Among them, Gan & Lee...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146180327","title":"Three Major Cross-Border Deals Land on Same Day, Boosting Sentiment for Chinese Innovative Drug Outbound Licensing; T+0 Huatai Baorui Hang Seng Innovative Drug ETF (520500) Attracts Over 2.5 Billion Yuan in Net Inflows Over the Past Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1146180327","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146180327?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:10","pubTimestamp":1786597841,"startTime":"0","endTime":"0","summary":"After years of sustained R&D investment, China's innovative drug industry is gradually moving past the early stage of heavy spending and profit pressure, with the profit realization capability of the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1161","MEDX","520500","06978","159992","IBBQ","BD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657648914","title":"Press Release: Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657648914","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657648914?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:30","pubTimestamp":1786102200,"startTime":"0","endTime":"0","summary":"Hawai i at Mānoa, it would be applying for CEPI funding to develop a. protein-based, thermostable vaccine targeting the Bundibugyo virus by. demonstrated with its filovirus vaccines. To view this press release,-- On May 26, 2026, in response to a recent Bundibugyo virus outbreak in the. Congo, the Company highlighted previous work with the University of Hawai. i, which has demonstrated platform compatibility with the key Bundibugyo. virus antigen enabling rapid development of a protein-based thermostable","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","BK4604","BK4588","CEPI","BK4099","BD","IDR","TM","03160","BK4585","R","SNGX","BK4168","BK4232","BK4022","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657363837","title":"BD Fiscal Q3 2026 Earnings: Revenue Grows as GAAP Operating Profit Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2657363837","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657363837?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:45","pubTimestamp":1786013105,"startTime":"0","endTime":"0","summary":"BD’s fiscal third-quarter 2026 revenue rose 5.4% to $4.983 billion, while diluted EPS from continuing operations increased 4.5% to $1.64 and adjusted EPS reached $3.23. GAAP operating income nevertheless declined 10.3% because operating costs grew faster than sales, creating a clear gap between top-line growth and reported profitability. All four operating segments posted revenue gains, led on a currency-neutral basis by Interventional. BD also lifted the lower end of full-year adjusted EPS guidance to $12.62, while expecting revenue growth toward the high end of its unchanged range.","market":"nz","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock3.jpg"],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262082600-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198410479","title":"Innovative Drug BD Deals Surpass 100 Billion in First Half, Signaling a Positive Long-Term Trend?","url":"https://stock-news.laohu8.com/highlight/detail?id=1198410479","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198410479?lang=en_us&edition=fundamental","pubTime":"2026-07-29 16:11","pubTimestamp":1785312692,"startTime":"0","endTime":"0","summary":"Since the start of 2026, the innovative drug index has experienced some adjustments from its initial levels. Some institutions believe this is primarily due to market factors like changing sector...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LNGR","BK1161","159992","06978","MEDX","BK1574","BD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117876984","title":"Insights from Biocytogen's CEO: The Fast-Track Four-Month BD Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1117876984","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117876984?lang=en_us&edition=fundamental","pubTime":"2026-07-22 16:22","pubTimestamp":1784708570,"startTime":"0","endTime":"0","summary":"From the formal initiation of discussions to the signing of the final agreement, the entire process took only about four months. Reflecting on the business development collaboration between...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BD","688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157011458","title":"Dalian's Dual Approach to Taxi Regulation: Strict Enforcement Meets Cultural Ambassadorship","url":"https://stock-news.laohu8.com/highlight/detail?id=1157011458","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157011458?lang=en_us&edition=fundamental","pubTime":"2026-07-21 12:20","pubTimestamp":1784607655,"startTime":"0","endTime":"0","summary":"A recent balanced approach to managing the taxi industry in Dalian has garnered significant public approval. The city's transportation authorities have implemented a strategy combining firm...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651849327","title":"AeroVironment in contract talks with U.S. Army over E-HEL program, BD says","url":"https://stock-news.laohu8.com/highlight/detail?id=2651849327","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651849327?lang=en_us&edition=fundamental","pubTime":"2026-07-16 03:35","pubTimestamp":1784144123,"startTime":"0","endTime":"0","summary":"Tthe U.S. Army could award contracts for its Common Autonomous Multi-Domain Launcher program in August, Breaking Defense’s Carley Welch reports, ci...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aerovironment-in-contract-talks-with-u-s-army-over-e-hel-program-bd-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aerovironment-in-contract-talks-with-u-s-army-over-e-hel-program-bd-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVAV","AVXX","BK4603","BD","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650292125","title":"Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2650292125","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650292125?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:23","pubTimestamp":1783599816,"startTime":"0","endTime":"0","summary":"Waters  could unlock stronger growth by turning around the recent acquired Becton Dickinson  biosciences and diagnostics businesses while benefiting from resilient demand tied to drug manufacturing, RBC Capital said in a Thursday note.Analysts said the acquired assets were under-managed rather than structurally weak and sees Waters' management applying its turnaround expertise to revive growth.RBC also expects the company to benefit from industry consolidation opportunities and its roughly 15% exposure to pharmaceutical manufacturing, which could gain from US re-shoring trends.RBC initiated coverage with an outperform rating and a $435 price target.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0068578508.USD","BK7067","LU0130518102.USD","BK4504","LU0072461881.USD","GB00B4QBRK32.GBP","LU0985489474.SGD","LU1201861165.SGD","WAT","LU1894683264.USD","LU0006061336.USD","LU0289739343.SGD","LU0511384066.AUD","LU0690374961.EUR","LU0289961442.SGD","LU1854103824.USD","LU2404859667.USD","LU1894683348.USD","LU0477156797.USD","LU2413666699.HKD","BD","IHI","LU1854104046.USD","LU1150488135.SGD","LU1150488218.USD","LU2413666426.HKD","BK4585","WAT.AU","IE00BFXG1179.USD","LU0266013472.USD","GB00B4LPDJ14.GBP","BK7118","LU0130103400.USD","BK4082","LU0878866978.SGD","BK4588","BDX.AU","BDX","LU0433182093.SGD","BK4121","LU1489326972.SGD","LU0985320562.USD","LU0648000940.SGD","LU0690374615.EUR","LU1059921491.USD","LU0162691827.USD","LU1721428933.USD","LU0347712357.USD","LU2404859741.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186814963","title":"Domestic Innovative Drug Secures Another Major $1.9 Billion Out-Licensing Deal, Sparking Rebound in Hong Kong Connect Pharma Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1186814963","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186814963?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:43","pubTimestamp":1783564987,"startTime":"0","endTime":"0","summary":"Another significant out-licensing agreement has been signed for a domestic innovative drug. China Biologic Products Holdings, Inc. has announced it has granted an exclusive license for its PDE3/4...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","MEDX","159992","BD","BK1574","FLHK","IBBQ","BK1161","520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166128362","title":"Hong Kong Stock Connect Biotech Stocks Surge, Leading ETF Jumps Over 3% as Record-High Licensing Deals Signal a Paradigm Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=1166128362","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166128362?lang=en_us&edition=fundamental","pubTime":"2026-07-08 10:14","pubTimestamp":1783476845,"startTime":"0","endTime":"0","summary":"Hong Kong Stock Connect-listed innovative drug stocks staged a powerful rebound during the morning session on July 8th. Leading shares such as Innovent Biologics and Akeso Inc. rose by 2.5%, while...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","FLHK","BK1161","IBBQ","520880","06978","159992","BK1574","KURE","BD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648298544","title":"Advent Hotels consolidates BD and P Hotels preference shares to back new debenture funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2648298544","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648298544?lang=en_us&edition=fundamental","pubTime":"2026-07-01 23:14","pubTimestamp":1782918889,"startTime":"0","endTime":"0","summary":"Advent Hotels International Limited ( ($IN:ADVENTHTL) ) just unveiled an update. Advent Hotels International Limited has approved the acquisition o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advent-hotels-consolidates-bd-and-p-hotels-preference-shares-to-back-new-debenture-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advent-hotels-consolidates-bd-and-p-hotels-preference-shares-to-back-new-debenture-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647766349","title":"Is Vizient’s Nod to BD CentroVena One Quietly Reframing Becton Dickinson’s (BDX) Competitive Moat?","url":"https://stock-news.laohu8.com/highlight/detail?id=2647766349","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647766349?lang=en_us&edition=fundamental","pubTime":"2026-06-29 06:14","pubTimestamp":1782684892,"startTime":"0","endTime":"0","summary":"Earlier this month, Becton, Dickinson and Company announced that its BD CentroVena One Insertion System received an Innovative Technology contract from Vizient, recognizing the all-in-one central venous catheter insertion system for its potential to simplify central line placement and enhance patient and clinician safety.\nThis endorsement from Vizient’s expert hospital councils highlights CentroVena One’s differentiated workflow and safety advantages, which could influence purchasing...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-vizients-nod-to-bd-centrovena-one-quietly-reframing-becto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-vizients-nod-to-bd-centrovena-one-quietly-reframing-becto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0985489474.SGD","LU1854104046.USD","LU1894683348.USD","LU1571399168.USD","BDX","LU0162691827.USD","BK4585","LU0130518102.USD","LU1894683264.USD","LU0289739343.SGD","BK7067","LU0648000940.SGD","LU1489326972.SGD","BK4504","LU0985320562.USD","LU0878866978.SGD","LU1201861165.SGD","LU0266013472.USD","BD","BK4082","LU0006061336.USD","LU0072461881.USD","LU0289961442.SGD","LU0068578508.USD","IE00BFXG1179.USD","LU0130103400.USD","LU0511384066.AUD","LU1150488218.USD","LU0433182093.SGD","LU1150488135.SGD","LU1854103824.USD","LU0477156797.USD","BDX.AU","BK4588","LU1059921491.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}